M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Genocea Biosciences decides not to pursue public offering due to market conditions
Biopharmaceutical company Genocea Biosciences (NasdaqGM:GNCA) said on Wednesday that it has elected not to proceed with its plans to pursue its public offering of 3,400,000 shares of its common stock.
The company remains well capitalized and expects that its existing cash and cash...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives